| Date Filed | Type | Description |
| 04/03/2023 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 800,000 options to buy
@ $0.91, valued at
$728k
|
|
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/16/2022 |
4
| MILLER RICHARD A MD (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.36, valued at
$34k
|
|
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2022 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 12,300 shares
@ $0.8101, valued at
$10k
Bought 2,700 shares
@ $0.82, valued at
$2.2k
Bought 5,000 shares
@ $0.815, valued at
$4.1k
|
|
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| MILLER RICHARD A MD (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.99, valued at
$49.8k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 15,000 shares
@ $1.6356, valued at
$24.5k
|
|
| 03/28/2022 |
4
| MILLER RICHARD A MD (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.03, valued at
$75.8k
|
|
| 03/17/2022 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 25,000 shares
@ $1.466, valued at
$36.7k
Bought 5,000 shares
@ $1.59, valued at
$8k
|
|
| 02/11/2022 |
SC 13G/A
| MILLER RICHARD A MD reports a 5.4% stake in Corvus Pharmaceuticals, Inc. |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
SC 13G/A
| MILLER RICHARD A MD reports a 7.5% stake in Corvus Pharmaceuticals, Inc. |
| 02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/17/2020 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 320,000 options to buy
@ $4.01, valued at
$1.3M
|
|
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/16/2019 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 320,000 options to buy
@ $3.54, valued at
$1.1M
|
|
| 11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2019 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 343 shares
@ $3.52, valued at
$1.2k
Bought 11,657 shares
@ $3.4028, valued at
$39.7k
|
|
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/31/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $3.2942, valued at
$65.9k
|
|
| 12/26/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $4.4, valued at
$22k
Bought 5,000 shares
@ $4.39, valued at
$22k
|
|
| 12/14/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Gifted 10,000 shares
@ $0
Granted 250,000 options to buy
@ $5.94, valued at
$1.5M
|
|
| 12/10/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $5.9868, valued at
$29.9k
|
|
| 12/06/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 1,502 shares
@ $5.95, valued at
$8.9k
|
|
| 03/12/2018 |
4
| MILLER RICHARD A MD (President and CEO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 100,000 shares
@ $8.5, valued at
$850k
|
|
|